Table 4 Clinical information of patients in the RT-PCR.
From: Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
Number | Age | Menstrual status | Tumor location | Pathological type | Tumor size | Clinical stages | Estrogen receptor (ER) | Progesterone receptor (PR) | Antigen KI67 (KI-67) | Human epidermal growth factor receptor-2 (HER-2) | Lymphatic metastasis | Histological grade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 61 | Postmenopause | Inner upper left breast | Invasive ductal carcinoma of the breast | 3.5*3*3 | IIA | Negative | Negative | 50% | Positive, 3 + | 0/13 | Grade III |
2 | 45 | Premenopausal | External upper right breast | Invasive ductal carcinoma of the breast | 2*1.5*1 | IIA | Positive | Positive | 30% | Negative | 4/15 | Grade I |
3 | 57 | Postmenopause | Behind the right nipple | Invasive ductal carcinoma | 2.5*2.0*1.5 | IIA | Positive | Positive | 40% | Positive, 3 + | 0/12 | Grade III |
4 | 51 | Postmenopause | External inferior right breast | Invasive ductal carcinoma | 1.5*1.5*1 | I | Positive | Positive | 30% | Positive, 3 + | 1/33 | Grade III |
5 | 60 | Postmenopause | External inferior right breast | Invasive ductal carcinoma | 2.3*1.8*1.8 | IIA | Positive | Positive | 70% | Positive, 3 + | 0/3 | Grade III |
6 | 51 | Postmenopause | Under the areola above right nipple | Invasive ductal carcinoma | 2.5*1.5*1.0 | IIA | Positive | Positive | 30% | Positive, 2 + | 1/27 | Grade III |
